{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:38:21Z","timestamp":1783993101607,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Postdoctoral research project of Chongqing Natural Science Foundation","award":["CSTB2023NSCQ-BHX0235"],"award-info":[{"award-number":["CSTB2023NSCQ-BHX0235"]}]},{"name":"the Chongqing medical scientific research project","award":["2024MSXM008"],"award-info":[{"award-number":["2024MSXM008"]}]},{"name":"the Chongqing medical scientific research project","award":["2024MSXM008"],"award-info":[{"award-number":["2024MSXM008"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M740443"],"award-info":[{"award-number":["2023M740443"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Chongqing postdoctoral research project special support","award":["2023CQBSHTB3076"],"award-info":[{"award-number":["2023CQBSHTB3076"]}]},{"name":"the Chongqing Natural Science Foundation project","award":["CSTB2022NSCQ-MSX0221"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0221"]}]},{"name":"the Chongqing Natural Science Foundation project","award":["CSTB2022NSCQ-MSX0892"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0892"]}]},{"name":"Chongqing Health appropriate technology extension project","award":["2023jstg047"],"award-info":[{"award-number":["2023jstg047"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171440"],"award-info":[{"award-number":["82171440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2023CDJYGRH-YB16"],"award-info":[{"award-number":["2023CDJYGRH-YB16"]}]},{"name":"the Chongqing Key Clinical Specialized Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77362-1","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T08:04:02Z","timestamp":1731312242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of genotype characteristics and drug resistance mutations in patients with chronic hepatitis B"],"prefix":"10.1038","volume":"14","author":[{"given":"Changlong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhousong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huacui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"6","key":"77362_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"Polaris Observatory C","year":"2018","unstructured":"Polaris Observatory C. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. Lancet Gastroenterol. Hepatol.3 (6), 383\u2013403 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"9959","key":"77362_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo, C., Chan, H. L. & Lok, A. Hepatitis B virus infection. Lancet. 384 (9959), 2053\u20132063 (2014).","journal-title":"Lancet"},{"issue":"9963","key":"77362_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD Mortality","year":"2015","unstructured":"Mortality, G. B. D. & Causes of Death, C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: A systematic analysis for the global burden of disease study 2013. Lancet. 385 (9963), 117\u2013171 (2015).","journal-title":"Lancet"},{"issue":"1","key":"77362_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","volume":"26","author":"KN Tsai","year":"2018","unstructured":"Tsai, K. N., Kuo, C. F. & Ou, J. J. Mechanisms of hepatitis B virus persistence. Trends Microbiol.26 (1), 33\u201342 (2018).","journal-title":"Trends Microbiol."},{"issue":"2","key":"77362_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1053\/j.gastro.2018.07.058","volume":"156","author":"AL McNaughton","year":"2019","unstructured":"McNaughton, A. L. et al. Insights from deep sequencing of the HBV genome-unique, tiny, and misunderstood. Gastroenterology. 156 (2), 384\u2013399 (2019).","journal-title":"Gastroenterology"},{"issue":"1","key":"77362_CR6","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1080\/22221751.2020.1835446","volume":"9","author":"Y Fu","year":"2020","unstructured":"Fu, Y. et al. Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients. Emerg. Microbes Infect.9 (1), 2381\u20132393 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"77362_CR7","doi-asserted-by":"publisher","first-page":"105348","DOI":"10.1016\/j.antiviral.2022.105348","volume":"203","author":"T Liu","year":"2022","unstructured":"Liu, T., Sun, Q., Gu, J., Cen, S. & Zhang, Q. Characterization of the tenofovir resistance-associated mutations in the hepatitis B virus isolates across genotypes a to D. Antiviral Res.203, 105348 (2022).","journal-title":"Antiviral Res."},{"issue":"9","key":"77362_CR8","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1158\/0008-5472.CAN-10-3100","volume":"71","author":"N Ren","year":"2011","unstructured":"Ren, N. et al. Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma. Cancer Res.71 (9), 3278\u20133286 (2011).","journal-title":"Cancer Res."},{"issue":"1","key":"77362_CR9","doi-asserted-by":"publisher","first-page":"13948","DOI":"10.1038\/s41598-019-50173-5","volume":"9","author":"J Tao","year":"2019","unstructured":"Tao, J. et al. Prevalence of hepatitis B virus infection in Shenzhen, China, 2015\u20132018. Sci. Rep.9 (1), 13948 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"77362_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/147323001003800122","volume":"38","author":"DD Li","year":"2010","unstructured":"Li, D. D. et al. Prevalence of hepatitis B virus genotypes and their relationship to clinical laboratory outcomes in Tibetan and Han Chinese. J. Int. Med. Res.38 (1), 195\u2013201 (2010).","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"77362_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/hep.20500","volume":"41","author":"JH Kao","year":"2005","unstructured":"Kao, J. H. & Chen, D. S. HBV genotypes and outcome of HBV infection. Hepatology. 41 (1), 216 (2005). author reply 216.","journal-title":"Hepatology"},{"key":"77362_CR12","doi-asserted-by":"publisher","first-page":"17413","DOI":"10.1038\/srep17413","volume":"5","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. Epidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from Western China. Sci. Rep.5, 17413 (2015).","journal-title":"Sci. Rep."},{"issue":"2","key":"77362_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/135965350801300217","volume":"13","author":"J Wiegand","year":"2008","unstructured":"Wiegand, J., Hasenclever, D. & Tillmann, H. L. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. Antivir Ther.13 (2), 211\u2013220 (2008).","journal-title":"Antivir Ther."},{"issue":"3","key":"77362_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1440-1746.2004.03572.x","volume":"20","author":"K Watanabe","year":"2005","unstructured":"Watanabe, K. et al. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations. J. Gastroenterol. Hepatol.20 (3), 441\u2013449 (2005).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"77362_CR15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1053\/j.gastro.2004.09.048","volume":"127","author":"YH Ni","year":"2004","unstructured":"Ni, Y. H. et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 127 (6), 1733\u20131738 (2004).","journal-title":"Gastroenterology"},{"issue":"7","key":"77362_CR16","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/gast.2002.33588","volume":"122","author":"CJ Chu","year":"2002","unstructured":"Chu, C. J., Hussain, M. & Lok, A. S. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology. 122 (7), 1756\u20131762 (2002).","journal-title":"Gastroenterology"},{"issue":"3","key":"77362_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1440-1746.2004.03572.x","volume":"20","author":"K Watanabe","year":"2005","unstructured":"Watanabe, K. et al. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations. J. Gastroen Hepatol.20 (3), 441\u2013449 (2005).","journal-title":"J. Gastroen Hepatol."},{"issue":"Suppl 1","key":"77362_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jgh.12220","volume":"28","author":"Y Cui","year":"2013","unstructured":"Cui, Y. & Jia, J. Update on epidemiology of hepatitis B and C in China. J. Gastroen Hepatol.28 (Suppl 1), 7\u201310 (2013).","journal-title":"J. Gastroen Hepatol."},{"key":"77362_CR19","doi-asserted-by":"crossref","unstructured":"Sunbul, M. Hepatitis B virus genotypes: Global distribution and clinical importance. World J. Gastroenterol.20(18). (2014).","DOI":"10.3748\/wjg.v20.i18.5427"},{"issue":"s1","key":"77362_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","volume":"26","author":"CL Lin","year":"2011","unstructured":"Lin, C. L. & Kao, J. H. The clinical implications of hepatitis B virus genotype: Recent advances. J. Gastroenterol. Hepatol.26 (s1), 123\u2013130 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"77362_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJM199907013410104","volume":"341","author":"I Cacciola","year":"1999","unstructured":"Cacciola, I. et al. Occult Hepatitis B virus infection in patients with chronic hepatitis C liver disease. New. Engl. J. Med.341 (1), 22\u201326 (1999).","journal-title":"New. Engl. j. med."},{"issue":"4","key":"77362_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jnci\/dji043","volume":"97","author":"MW Yu","year":"2005","unstructured":"Yu, M. W. et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. Jnci-J. Natl. Cancer I. 97 (4), 265\u2013272 (2005).","journal-title":"Jnci-j natl. cancer i"},{"issue":"4","key":"77362_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jnci\/dji043","volume":"97","author":"MW Yu","year":"2005","unstructured":"Yu, M. W. et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men. J. Natl. Cancer Inst.97 (4), 265\u2013272 (2005).","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"77362_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1053\/j.gastro.2007.08.010","volume":"133","author":"SE Livingston","year":"2007","unstructured":"Livingston, S. E. et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 133 (5), 1452\u20131457 (2007).","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"77362_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","volume":"26","author":"CL Lin","year":"2011","unstructured":"Lin, C. L. & Kao, J. H. The clinical implications of hepatitis B virus genotype: Recent advances. J. Gastroenterol. Hepatol.26 (Suppl 1), 123\u2013130 (2011).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"77362_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","volume":"67","author":"N Rajoriya","year":"2017","unstructured":"Rajoriya, N., Combet, C., Zoulim, F. & Janssen, H. L. A. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J. Hepatol.67 (6), 1281\u20131297 (2017).","journal-title":"J. Hepatol."},{"issue":"7","key":"77362_CR27","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1111\/j.1365-2893.2011.01435.x","volume":"18","author":"S Mirandola","year":"2011","unstructured":"Mirandola, S. et al. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B. J. Viral Hepat.18 (7), e212\u2013216 (2011).","journal-title":"J. Viral Hepat."},{"issue":"5","key":"77362_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","volume":"137","author":"F Zoulim","year":"2009","unstructured":"Zoulim, F. & Locarnini, S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 137 (5), 1593\u20131608e1591 (2009).","journal-title":"Gastroenterology"},{"issue":"4","key":"77362_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/mdr.2016.0093","volume":"23","author":"X Li","year":"2017","unstructured":"Li, X. et al. Comparison of detection rate and mutational pattern of drug-resistant mutations between a large cohort of genotype B and genotype C hepatitis B virus-infected patients in North China. Microb. Drug Resist.23 (4), 516\u2013522 (2017).","journal-title":"Microb. Drug Resist."},{"issue":"9","key":"77362_CR30","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3855\/jidc.8020","volume":"10","author":"F Qian","year":"2016","unstructured":"Qian, F. et al. Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China. J. Infect. Dev. Ctries.10 (9), 996\u20131002 (2016).","journal-title":"J. Infect. Dev. Ctries."},{"key":"77362_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jgar.2016.10.012","volume":"8","author":"T Meng","year":"2017","unstructured":"Meng, T. et al. Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010\u20132014). J. Glob. Antimicrob. Resist.8, 74\u201381 (2017).","journal-title":"J. Glob Antimicrob. Resist."},{"issue":"4","key":"77362_CR32","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/j.1365-2893.2010.01360.x","volume":"18","author":"Y Liu","year":"2011","unstructured":"Liu, Y. et al. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection. J. Viral Hepat.18 (4), e29\u201339 (2011).","journal-title":"J. Viral Hepat."},{"issue":"2","key":"77362_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijantimicag.2018.04.002","volume":"52","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Trends in hepatitis B virus resistance to nucleoside\/nucleotide analogues in North China from 2009\u20132016: A retrospective study. Int. J. Antimicrob. Agents. 52 (2), 201\u2013209 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"23","key":"77362_CR34","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.3748\/wjg.v23.i23.4222","volume":"23","author":"JE Kim","year":"2017","unstructured":"Kim, J. E. et al. Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-na\u00efve Korean patients infected with genotype C2. World J. Gastroenterol.23 (23), 4222\u20134232 (2017).","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"77362_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.7883\/yoken.JJID.2017.078","volume":"70","author":"LN Yamani","year":"2017","unstructured":"Yamani, L. N. et al. Profile of mutations in the reverse transcriptase and overlapping surface genes of hepatitis B virus (HBV) in treatment-Na\u00efve Indonesian HBV carriers. Jpn J. Infect. Dis.70 (6), 647\u2013655 (2017).","journal-title":"Jpn J. Infect. Dis."},{"issue":"11\u201312","key":"77362_CR36","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1365-2036.2009.04151.x","volume":"30","author":"MH Nguyen","year":"2009","unstructured":"Nguyen, M. H. et al. Prevalence of hepatitis B virus DNA polymerase mutations in treatment-na\u00efve patients with chronic hepatitis B. Aliment Pharmacol. Ther.30 (11\u201312), 1150\u20131158 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"77362_CR37","unstructured":"Chen, X. H., GD, X. & SQ, L. Z. N: Study on hepatitis B virus genotype and drug resistance gene mutation in chronic hepatitis B patients in Guangxi, Yunnan and Guizhou border areas. Vaccines and Immunization in China 27(4)366\u2013369 2021. (2021)."},{"issue":"1","key":"77362_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11262-017-1518-z","volume":"54","author":"HY Zhang","year":"2018","unstructured":"Zhang, H. Y. et al. Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010\u20132016). Virus Genes. 54 (1), 41\u201347 (2018).","journal-title":"Virus Genes"},{"issue":"2","key":"77362_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bjid.2015.12.006","volume":"20","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with chronic hepatitis B in Central China. Braz J. Infect. Dis.20 (2), 173\u2013178 (2016).","journal-title":"Braz J. Infect. Dis."},{"key":"77362_CR40","unstructured":"Tao, X. et al. Genotyping and drug resistance mutation analysis of hepatitis B virus in West China Hospital of Sichuan University. West. China Med.2019(8):5 ."},{"issue":"4","key":"77362_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","volume":"5","author":"J Hou","year":"2017","unstructured":"Hou, J. et al. Guideline of prevention and treatment for chronic hepatitis B (2015 update). J. Clin. Transl Hepatol.5 (4), 297\u2013318 (2017).","journal-title":"J. Clin. Transl Hepatol."},{"issue":"3","key":"77362_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3343\/alm.2014.34.3.230","volume":"34","author":"AJ Lee","year":"2014","unstructured":"Lee, A. J., Lee, C. H. & Jeon, C. H. Analysis of reverse transcriptase gene mutations in the hepatitis B virus at a university hospital in Korea. Ann. Lab. Med.34 (3), 230\u2013234 (2014).","journal-title":"Ann. Lab. Med."},{"issue":"1","key":"77362_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.20016","volume":"39","author":"B Zollner","year":"2004","unstructured":"Zollner, B. et al. Viral features of lamivudine resistant hepatitis B genotypes a and D. Hepatology. 39 (1), 42\u201350 (2004).","journal-title":"Hepatology"},{"issue":"3","key":"77362_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0168-8278(01)00283-5","volume":"36","author":"M Buti","year":"2002","unstructured":"Buti, M. et al. Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine? J. Hepatol.36 (3), 445\u2013446 (2002).","journal-title":"J. Hepatol."},{"key":"77362_CR45","doi-asserted-by":"crossref","unstructured":"Fu, Y. et al. Characterization and clinical significance of natural variability in hepatitis B virus reverse transcriptase in treatment-Naive Chinese patients by Sanger sequencing and next-generation sequencing. J. Clin. Microbiol.57(8). (2019).","DOI":"10.1128\/JCM.00119-19"},{"issue":"3","key":"77362_CR46","doi-asserted-by":"publisher","first-page":"e28612","DOI":"10.1002\/jmv.28612","volume":"95","author":"H Liao","year":"2023","unstructured":"Liao, H. et al. Nucleos(t)ide analogues altered quasispecies composition of hepatitis B virus (HBV)-resistant mutations in serum HBV DNA and serum HBV RNA. J. Med. Virol.95 (3), e28612 (2023).","journal-title":"J. Med. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77362-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:17:26Z","timestamp":1731655046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77362-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77362"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77362-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4057682\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"27575"}}